Alpha Tau Announces Multiple Corporate Updates Ahead of 2022 Annual Meeting of the American Society for Radiation Oncology
October 21, 2022 16:01 ET
|
Alpha Tau Medical Ltd.
- Medicines and Healthcare products Regulatory Agency of the United Kingdom approves clinical trial in squamous cell carcinoma of the vulva at Addenbrookes Hospital in Cambridge - - Health Canada...
ROSEN, A LEADING LAW FIRM, Encourages Terra Tokens Investors With Losses to Secure Counsel Before Important August 19 Deadline in Securities Class Action – UST, LUNA, KRT, ANC, WHALE, ASTRO, APOLLO, XDEFI, MINE, aUST, vUST, MIR, mBTC, mETH, mVIXY, mTSLA, UST-mVIXY-LP, bLUNA-LUNA-LP, XDEFI-UST-LP, bLUNA, bETH
August 02, 2022 15:00 ET
|
The Rosen Law Firm PA
NEW YORK, Aug. 02, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Terra Tokens, including UST, LUNA, KRT, ANC, WHALE, ASTRO, APOLLO, XDEFI,...
ROSEN, A LEADING LAW FIRM, Encourages Terra Tokens Investors to Secure Counsel Before Important Deadline in Securities Class Action – UST, LUNA, KRT, ANC, WHALE, ASTRO, APOLLO, XDEFI, MINE, aUST, vUST, MIR, mBTC, mETH, mVIXY, mTSLA, UST-mVIXY-LP, bLUNA-LUNA-LP, XDEFI-UST-LP, bLUNA, bETH
July 28, 2022 13:18 ET
|
The Rosen Law Firm PA
NEW YORK, July 28, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Terra Tokens, including UST, LUNA, KRT, ANC, WHALE, ASTRO, APOLLO, XDEFI,...
Fantagio to Host Its First Music Hackathon Starting April 25 for Its Upcoming Global Launch of an NFT Meta Idol, Composers Around the World Can Participate as Contestants
April 20, 2022 02:00 ET
|
Fantagio
SINGAPORE, April 20, 2022 (GLOBE NEWSWIRE) -- Fantagio, a KOSDAQ-listed South Korean entertainment powerhouse, announced its plans to host Fantagio Music Hackathon, a global audition for aspiring...
Study Demonstrates Superiority of VeraForm® Marker Over Clips for Tumor Bed Delineation Accuracy
October 28, 2021 15:00 ET
|
Videra Surgical
SAN FRANCISCO, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Videra Surgical Inc., the developer of the novel adaptable tumor bed marker VeraForm® for breast cancer surgery, announced the presentation of an...
Gerry Vantellingen Joins Akesis as President
October 22, 2020 10:39 ET
|
Akesis
CONCORD, Calif., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Gerry Vantellingen has joined Akesis as President, the company announced today. Vantellingen has held a variety of global leadership positions with...
Akesis Galaxy™ SRS System Receives 510(k) Clearance
September 13, 2019 08:00 ET
|
Akesis
CONCORD, Calif., Sept. 13, 2019 (GLOBE NEWSWIRE) -- The Akesis Galaxy™, a gamma stereotactic radiosurgery system (SRS) with continuous 360o rotational technology, has received 510(k) clearance from...
BCSC removes CTO in Canada
October 23, 2018 10:21 ET
|
Astro Aerospace Ltd.
Dallas, Texas, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Astro Aerospace Ltd. (the “Company” or “Astro”) (OTCQB: ASDN) and its wholly-owned subsidiaries, announces that effective __Monday Oct 22, 2018, the...
Nanobiotix présentera les résultats positifs de son étude de phase II/III évaluant NBTXR3 dans les Sarcomes Des Tissus Mous (STM) et de ses autres études de phase I/II aux prochains congrès annuels de l’ESMO et de l’ASTRO
September 26, 2018 02:00 ET
|
NANOBIOTIX
NANOBIOTIX PRESENTERA LES RESULTATS POSITIFS DE SON ETUDE DE PHASE II/III EVALUANT NBTXR3 DANS LES SARCOMES DES TISSUS MOUS (STM) ET DE SES AUTRES ETUDES DE PHASE I/II AUX PROCHAINS CONGRES...
Nanobiotix to present positive results from its phase II/III clinical trial of NBTXR3 in patients with Soft Tissue Sarcoma (STS) and other ongoing phase I/II trials at upcoming ESMO and ASTRO annual conferences
September 26, 2018 02:00 ET
|
NANOBIOTIX
NANOBIOTIX TO PRESENT POSITIVE RESULTS FROM ITS PHASE II/III CLINICAL TRIAL OF NBTXR3 IN PATIENTS WITH SOFT TISSUE SARCOMA (STS) AND OTHER ONGOING PHASE I/II TRIALS AT UPCOMING ESMO AND ASTRO...